Form 4: Sangamo Therapeutics CFO Reports Stock Transactions for Tax Withholding
SEC Form 4 Filing
Prathyusha Duraibabu, CFO of Sangamo Therapeutics, reports disposition of shares to cover tax obligations related to vesting restricted stock units (RSUs).
Summary
- On August 24 and 25, 2024, Prathyusha Duraibabu, the SVP and CFO of Sangamo Therapeutics, disposed of shares of common stock to cover mandatory tax withholding requirements related to the vesting of restricted stock units (RSUs).
- A total of 1,787 shares were disposed of on August 24, 2024, and 1,371 shares were disposed of on August 25, 2024, both at a price of $0.86 per share.
- These transactions were not discretionary trades but were required under the terms of the company's Amended and Restated 2018 Equity Incentive Plan.
- Following these transactions, Duraibabu beneficially owns 827,370 shares of Sangamo Therapeutics common stock.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions for tax purposes, with no indication of positive or negative sentiment.
Industry Context
This is a routine filing related to executive compensation and tax obligations. It doesn't necessarily reflect a change in the company's outlook or strategy.
Key Dates
| Date | Description |
|---|---|
| 08/24/2024 | Date of first reported transaction: disposition of 1,787 shares for tax withholding. |
| 08/25/2024 | Date of second reported transaction: disposition of 1,371 shares for tax withholding. |
| 08/27/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.